TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Avadel Receives Unsolicited Proposal from Lundbeck

Benzinga Logo Benzinga By Globe Newswire
Avadel Receives Unsolicited Proposal from Lundbeck

Pharmaceutical company Avadel received an unsolicited acquisition proposal from Lundbeck for $23.00 per share, which the Avadel Board believes could potentially be a 'Company Superior Proposal' to their existing agreement with Alkermes.

Insights
PBMWW   positive

Company is expanding strategic partnership, making significant investment, and positioning itself as a leader in psychedelic therapeutics research


AVDL   neutral

Currently evaluating an unsolicited proposal while maintaining existing merger agreement, indicating strategic consideration without definitive commitment